Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

St. Jude Children's Research Hospital to launch new Department of Imaging Sciences
The new Department of Imaging Sciences will be spearheaded by Elizabeth M.C. Hillman, PhD, a physicist, biomedical engineer, neuroscience researcher and inventor.
Chemical alterations in the brain hint at whether loss of smell will return post-COVID
Researchers have identified what they believe could serve as imaging biomarkers that predict recovery from anosmia after contracting the virus.
Early outcomes with Myval TAVR valve comparable to popular devices from Medtronic, Edwards
Meril Life Sciences has been manufacturing its Myval heart valves for years. The devices are approved and available in both India and Europe, but they have not been approved by the FDA.
Surgeons make history again with world’s first robotic implant of Abbott heart device
The historic LVAD implant was performed on a 35-year-old patient with advanced heart failure. His symptoms included kidney and lung deterioration.
Q&A: Society of Thoracic Surgeons president previews the trends and technologies of STS 2025
It looked like the wildfires in Los Angeles could force STS to cancel its annual meeting, but the group worked with city officials and was able to carry on as planned. STS President Jennifer C. Romano, MD, MS, discussed that difficult decision and previewed the three-day event in a new interview.

"Every clinical outcome that we measured favored treatment with valsartan alone," one researcher said.

These individuals are less likely to benefit from COVID-19 vaccines, according to a recent study from the Centers for Disease Control and Prevention.

The study's authors said that policies should be put in place to provide better support for these individuals.

One facility saw vascular surgeon consultations increase by more than 500% over the course of 15 years.

Researchers examined data from the CardioMEMS Post Approval Study, sharing their findings in JACC: Heart Failure.

The team behind the new pilot study said additional research is still necessary to confirm its findings.

Patients continue to see the benefits of transcatheter mitral valve replacement a full two years after treatment.

The American Heart Association has shared a new scientific statement on the topic.